BTN3A2 and rheumatoid arthritis: Studies using one or more anti-rheumatic drugs (methometamine, hydroxychloroquine, or sulfonamide) on 46 patients with suspected RA, followed by a genome-wide methylation analysis of baseline T lymphocyte DNA found that the BTN3A2 gene is Two CpG sites are closely related to a treatment response (38).